Salivary duct carcinoma. Part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature.
about
Primary ductal adenocarcinoma of the lacrimal sac: the first reported caseAn immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma.Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.Case report: anti-hormonal therapy in the treatment of ductal carcinoma of the parotid glandPostoperative radiotherapy in salivary ductal carcinoma: a single institution experience.Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analysesMinor salivary gland tumors in the Indian population: A series of cases over a ten year period.Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour.Salivary duct carcinoma: A clinopathological report of 11 cases.Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glandsTrastuzumab for the treatment of salivary duct carcinoma.Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan.Salivary duct carcinoma: what is already known, and can we improve survival?Salivary gland carcinomas.Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.Is there a role of adjuvant treatment for salivary duct carcinoma?Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.Salivary duct carcinoma: a Danish national study.Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas.Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases.Salivary duct carcinoma in the mandibular anterior region: The role of immunohistochemical markers in its definitive diagnosis.Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma.Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report.Salivary duct carcinoma: Treatment, outcomes, and patterns of failure.Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.Immunohistochemical analysis of thymic carcinoma focusing on the possibility of molecular targeted and hormonal therapies.Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients.Intratumoral heterogeneity of HER2 protein and amplification of HER2 gene in salivary duct carcinoma.Primary ductal adenocarcinoma of lacrimal gland: Two case reports and review of the literature.
P2860
Q26828890-5D10B238-29A6-46C0-B438-70CD1DDB9E4FQ33619720-1AECD4BE-7AF4-457B-90E2-441CC2D4FDE1Q34125003-58CA691F-D3A8-4334-BD5B-F70D0CE524DEQ34308966-51AF1E7E-5EFF-43D3-B118-88D104594866Q34325443-1C37A304-AAD5-4777-B3FA-9CE1DD33C7C2Q34714945-2BE40441-F260-446B-84FF-A11074100130Q34975016-707AE2CD-0B28-40BF-B13D-B6BE4D38D047Q35015524-EE92822F-50B6-41E3-9A6F-8521B13C5ED2Q35587213-474BED69-D306-4CB2-9528-4C42AA7AE92FQ35803825-259B0FC1-07B5-4E64-B026-D6097B253177Q35915236-86681ACB-F433-4EC5-A1DB-F4E1E5A98815Q36325917-6398EDB2-1E35-4051-9B77-F57548EC79DBQ36714388-1B7149EE-969B-48FC-8D94-94ADDAC7B4D6Q36874710-0B5C26F3-67AB-4A00-9C4C-0D244D322165Q37702050-BC2FC131-7623-421E-A2C5-B30185019EC4Q38001863-D977049C-7144-4AEF-931E-49201565A509Q38030395-D876E906-38BA-4F20-B1C3-FA5A9B233794Q38114366-F2581F80-9D34-4A12-877A-F90AF4A027C7Q38364289-CB015A18-4C97-46D6-9717-9EABE0BAD7C8Q39491094-4EB0FF5C-A41F-4912-B575-D66491F7332FQ40046991-0F86868F-0016-4524-9B68-06535EE04CB6Q40783341-6C6F70E1-3DBD-49B8-B592-CB61BF013BC6Q40984137-7A32318D-0B7A-4F25-A216-C61BADD12E40Q41332172-A13E708A-FD63-4236-857F-C8D060E844C5Q41906992-4F57BAF5-AD16-4F88-89D1-86440E5FB365Q42233857-BDFA84B9-4323-49B2-A514-E19584952797Q47569604-0607CE4C-7DFA-45BB-9A97-4AEEC0EF5924Q48123633-D1773A16-7A7D-421C-BC37-37891B0B99B9Q50905277-C4AA70A4-4EEB-41F2-BE37-9DAAEAA250F4Q53176642-A584E180-66D1-4723-9F37-FE312A783FB4Q54323253-485FD6CB-B339-4D5E-90AF-16CB16CE4742Q55279483-03778B26-DD3A-4E1E-A127-EBDE0FDA2020
P2860
Salivary duct carcinoma. Part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Salivary duct carcinoma. Part ...... with review of the literature.
@en
type
label
Salivary duct carcinoma. Part ...... with review of the literature.
@en
prefLabel
Salivary duct carcinoma. Part ...... with review of the literature.
@en
P2093
P1476
Salivary duct carcinoma. Part ...... with review of the literature.
@en
P2093
P356
10.1016/0030-4220(94)90119-8
P577
1994-07-01T00:00:00Z